Technical Research on Healthcare Equities -- Rennova Health, Cerner, Veeva Systems, and Teladoc

Tuesday, June 6, 2017 Research News
Email Print This Page Comment bookmark
Font : A-A+

NEW YORK, June 6, 2017 /PRNewswire/ --

Pre-market today, revisits the Healthcare Information

Services space, which consists of a set of corporations that provide data, products, and services to customers, ranging from hospitals and physician practices to pharmaceutical and biotech companies, and to private individuals. Equities under review
this morning are: Rennova Health Inc. (NASDAQ: RNVA), Cerner Corp. (NASDAQ: CERN), Veeva Systems Inc. (NYSE: VEEV), and Teladoc Inc. (NYSE: TDOC). Take a look at the free research reports issued today on for these stocks by signing up at:

Rennova Health 

On Monday, shares in West Palm Beach, Florida headquartered Rennova Health Inc. recorded a trading volume of 130,653 shares. The stock ended the day at $0.38, declining 2.06% from the last trading session. The Company's shares are trading below their 50-day moving average by 61.82%. Furthermore, shares of Rennova Health, which provides diagnostics and supportive software solutions to healthcare providers, have a Relative Strength Index (RSI) of 21.26.

On June 01st, 2017, Rennova Health announced the postponement of its Special Meeting of Stockholders that was to have taken place originally on May 19th, 2017, but was subsequently postponed to May 26th, 2017, and then again to June 02nd, 2017. The new date for the Special Meeting is June 09th, 2017, at 11:00 a.m. ET, and it will take place at the offices of Shutts & Bowen LLP, 525 Okeechobee Boulevard, Suite 1100, West Palm Beach, FL 33401. Sign up and read the free research report on RNVA at:


North Kansas City, Missouri headquartered Cerner Corp.'s stock rose 0.73%, finishing yesterday's session at $67.91. A total volume of 3.87 million shares was traded, which was above their three months average volume of 2.79 million shares. The Company's shares have gained 5.91% in the last month, 23.29% over the previous three months, and 43.36% since the start of this year. The stock is trading above its 50-day and 200-day moving averages by 9.67% and 19.01%, respectively. Additionally, shares of Cerner, which designs, develops, markets, installs, hosts, and supports health care information technology, health care devices, hardware, and content solutions for health care organizations and consumers in the US and internationally, have an RSI of 76.82.

On May 15th, 2017, research firm Bank of America/ Merrill upgraded the Company's stock rating from 'Underperform' to 'Neutral'.

On May 26th, 2017, Cerner announced the 2017 Cerner Nursing Assistant of the Year Scholarship recipient, Amber Jasper, of Garden Valley Nursing and Rehabilitation Center in Kansas City, Missouri. Jasper was nominated by Diona Kern, director of Human Resources and Payroll at Garden Valley Nursing and Rehabilitation Center. The Cerner Nursing Assistant of the Year Scholarship Program awarded Jasper a $3,000 scholarship to offset educational expenses. The complimentary research report on CERN can be downloaded at:

Veeva Systems 

Shares in Pleasanton, California headquartered Veeva Systems Inc. ended the session 1.47% lower at $65.72. The stock recorded a trading volume of 1.66 million shares, which was above its three months average volume of 1.55 million shares. The Company's shares have gained 21.32% in the last one month, 49.19% over the previous three months, and 61.47% on an YTD basis. The stock is trading 19.49% above its 50-day moving average and 45.33% above its 200-day moving average. Moreover, shares of Veeva Systems, which provides cloud-based software for the life sciences industry in North America, Europe, Asia/Pacific, and internationally, have an RSI of 68.04.

On June 01st, 2017, Veeva Systems announced participation in the Bank of America Merrill Lynch 2017 Global Technology Conference in San Francisco, CA. Tim Cabral, CFO, is presenting on June 07th, 2017, at 3:35 p.m. PT.

On June 05th, 2017, research firm Morgan Stanley downgraded the Company's stock rating from 'Overweight' to 'Equal-Weight'. Register for free on and access the latest report on VEEV at:


At the closing bell on Monday, Purchase, New York headquartered Teladoc Inc.'s stock dropped 1.67%, finishing at $32.35. A total volume of 576,466 shares was traded. The Company's shares have surged 30.18% in the last month, 54.05% over the previous three months, and 96.06% on an YTD basis. The stock is trading 21.24% and 57.62% above its 50-day and 200-day moving averages, respectively. Additionally, shares of Teladoc, which operates a telehealth platform that provides on-demand healthcare services to its members in the US, have an RSI of 66.29.  

On May 18th, 2017, research firm KeyBanc Capital Markets initiated an 'Overweight' rating on the Company's stock, with a target price of $37 per share.

On June 01st, 2017, Teladoc announced that Jason Gorevic, President and CEO, and Mark Hirschhorn, COO and CFO, will participate in the William Blair 2017 Growth Stock Conference, to be held on June 14th, 2017, in Chicago, IL, including a fireside chat at 11:40 a.m. ET. Get free access to your research report on TDOC at:


Daily Stock Tracker: 

Daily Stock Tracker (DST) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. DST has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below. 

DST has not been compensated; directly or indirectly; for producing or publishing this document. 


The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on analyst credentials, please email Rohit Tuli, a CFA® charterholder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by DST. DST is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.  


DST, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. DST, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, DST, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice. 


This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither DST nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit

CONTACT For any questions, inquiries, or comments reach out to us directly. If you're a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at: Email: Phone number:  (207) 331.3313 Office Address: 377 Rivonia Boulevard, Rivonia, South Africa

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE Chelmsford Park SA

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z


News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store